Infection due to aciclovir resistant herpes simplex virus in patients undergoing allogeneic hematopoetic stem cell transplantation

Pathologie Biologie

Volumn 49, Issue 7, 2001, Pages 553-558

  Venard, V ^a   Dauendorffer, J N ^a   Carret, A S ^b   Corsaro, D ^a   Edert, D ^a   Bordigoni, P ^a   Le Faou, A ^a  

^a UNIVERSITÉ DE LORRAINE   (France)

^b HÔPITAL D ENFANTS   (France)

Author keywords

Aciclovir resistance; Bone marrow transplantation; Herpes simplex virus 1; Thymidine kinase gene

Indexed keywords

ACICLOVIR; CIDOFOVIR; FOSCARNET; THYMIDINE KINASE; VALACICLOVIR; ANTIVIRUS AGENT; CYTOSINE; DRUG DERIVATIVE; ORGANOPHOSPHORUS COMPOUND; PHOSPHONIC ACID DERIVATIVE; VALINE; VIRUS PROTEIN;

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; CASE REPORT; CHRONIC MYELOID LEUKEMIA; CONFERENCE PAPER; EPSTEIN BARR VIRUS; FEMALE; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 1; HUMAN; IMMUNE DEFICIENCY; MALE; NONHODGKIN LYMPHOMA; SCHOOL CHILD; SKIN INFECTION; VIRUS ISOLATION; ACUTE DISEASE; ALLOTRANSPLANTATION; AMINO ACID SUBSTITUTION; ANTIBIOTIC RESISTANCE; ARTICLE; BONE MARROW TRANSPLANTATION; CHILD; CODON; DRUG EFFECT; ENZYMOLOGY; GENETICS; GROWTH, DEVELOPMENT AND AGING; HERPES SIMPLEX VIRUS; ISOLATION AND PURIFICATION; MISSENSE MUTATION; MORTALITY; MYELOID LEUKEMIA; NUCLEOTIDE SEQUENCE; POINT MUTATION; SALVAGE THERAPY; VIROLOGY; VIRUS ACTIVATION;

ACUTE DISEASE; ACYCLOVIR; ADOLESCENT; AMINO ACID SUBSTITUTION; ANTIVIRAL AGENTS; BONE MARROW TRANSPLANTATION; CHILD; CODON; CYTOSINE; DNA MUTATIONAL ANALYSIS; DRUG RESISTANCE, VIRAL; FEMALE; FOSCARNET; GRAFT VS HOST DISEASE; HERPES SIMPLEX; HUMANS; IMMUNOCOMPROMISED HOST; LEUKEMIA, MYELOID; LEUKEMIA, MYELOID, CHRONIC; LYMPHOMA, NON-HODGKIN; MALE; MUTATION, MISSENSE; ORGANOPHOSPHORUS COMPOUNDS; PHOSPHONIC ACIDS; POINT MUTATION; SALVAGE THERAPY; SIMPLEXVIRUS; THYMIDINE KINASE; TRANSPLANTATION, HOMOLOGOUS; VALINE; VIRAL PROTEINS; VIRUS ACTIVATION;

EID: 0034804789     PISSN: 03698114     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0369-8114(01)00205-X     Document Type: Conference Paper

References (17)

1. Recurrent infection with herpes simplex virus after marrow transplantation: Role of the specific immune response and acyclovir treatment
2. Acyclovir prophylaxis of herpes simplex virus infections. A randomized, double-blind, controlled trial in bone-marrow-transplant recipients
3. Oral acyclovir for prevention of herpes simplex virus reactivation after Bone Marrow transplantation
4. Resistant Herpes Simplex Virus type 1 infection: An emerging concern after allogeneic stem cell transplantation
5. Acyclovir-resistant herpes simplex virus infections in patients with the acquired immunodeficiency syndrome
6. Acyclovir-resistant herpes simplex virus infections in a bone marrow transplant population
7. Investigation of aciclovir-resistant Herpes Simplex Virus 1 infection in a bone marrow transplantation unit: Genotyping shows that different strains are involved
8. Susceptibility of clinical strains of Herpes Simplex virus to three nucleoside analogs
9. Occurrence and characterization of acyclovir-resistant herpes simplex virus isolates: Report on a two-year sensitivity screening survey
10. Correlation between response to acyclovir and foscarnet therapy and in vitro susceptibility result for isolates of herpes simplex virus from human immunodeficiency virus-infected patients
11. Phenotypic genotypic characterization of acyclovir-resistant herpes simplex viruses from immunocompromised patients
12. Genetic characterization of thymidine kinase from aciclovir-resistant and -susceptible Herpes Simplex Virus type 1 isolated from bone marrow transplant recipients
13. European survey of herpesvirus resistance to antiviral drugs in bone marrow transplant recipients
14. Herpes viral thymidine kinases: Laxity and resistance by design
15. Recurrent acyclovir-resistant herpes simplex in an immunocompromised patient: Can strain differences compensate for loss of thymidine kinase in pathogenesis?
16. New therapeutic approaches to alphaherpesvirus infections
17. Antiviral therapy of herpes simplex virus infection: Recent developments